One of Our Top CBD Penny Stocks to Watch Could Soar 116%

Something big happened this week in the cannabis world. Aurora Cannabis (NYSE: ACB) announced on May 20 (Wednesday) that it’s entering the U.S. market.

This is great for cannabis stocks. But you shouldn’t ignore the benefit this has for cannabis’ favorite cousin: CBD.

One of our top CBD penny stocks to watch is poised for 116% gain. And this move by Aurora is a big part of that.

You see, Aurora is the second largest cannabis company in the world by market cap, next to Canopy Growth Corp. (NYSE: CGC). It’s basically a household name in the sector, one of the first names that comes up when you think of pot stocks on the NYSE.

So the fact that it’s entering the American market is fuel for the U.S. CBD industry as it gets rolling.

Though the tides are shifting, it’s still a while before recreational cannabis is legalized in the United States.

CBD, on the other hand, has been legal to carry across state lines since the Farm Bill of 2018. It’s also more readily accepted culturally in the United States.

In fact, CBD has been considered an “essential item” throughout the pandemic. You can even buy it at grocery stores like Kroeger and Harris Teeter.

CBD has done well for people struggling with anxiety, insomnia, and chronic pain during this time. Professional athletes like golfer Bubba Watson and football star Rob Gronkowski have even credited its healing and recovery properties.

These developments are pushing the CBD industry to hit $2 billion in sales by the end of 2020. But the market is on its way to reaching $20 billion worth by 2024. That’s 900% growth.

And it’s all 116% fuel for our top CBD stock today.

Unstoppable: Our new Premium Stock Pick kept climbing while the rest of the market tanked. And as a leader in a new billion-dollar market, the gains are just getting started. Don’t miss out – get this pick for free here

We’re going to show you that stock in just a moment. But first, here’s why this is a big deal for CBD investors right now.

CBD Stocks Get a Catalyst

Aurora’s shares popped 27% after announcing it would fully acquire Reliva LLC this year.

Aurora is Canada-based, and Reliva is an American company, started in Maine.

This is huge because the United States is already the largest legal cannabis market in the world. And there’s no better foot in the door than CBD, an industry that is even closer to explosive growth.

Reliva is also one of the top CBD retailers in the nation. The company sells products in more than 20,000 stores across the country.

And this deal looks good for both companies.

Reliva receives $40 billion worth of Aurora stock. Aurora promises $45 million in additional shares if the Reliva meets Aurora’s performance expectations down the road.

That means Aurora shareholders have a backstop if Reliva doesn’t perform as planned. But it also incentivizes Reliva to perform.

Aurora has made clear its goal of becoming an “international cannabinoid leader.” And Reliva will help the company do this.

The bottom line here, though, is that the American CBD industry is expanding. And you don’t want to miss out on holding this top CBD stock while it happens…

Here’s the CBD penny stock that could pop 116% on the CBD industry’s latest catalyst…

The Best CBD Penny Stock to Buy Now

HEXO Corp. (NYSE: HEXO) is one of the most important CBD penny stocks to watch right now. Like Aurora, it’s one of the more notable cannabis stocks trading on the NYSE.

But this company is poised to be a monster in the CBD industry.

Like Aurora, HEXO was one of the first movers in the marijuana sector. That gives it an advantage of stability and vision over other, newer players.

And this shows in the deals that HEXO has made with other companies, across industries.

This company partnered with Molson Coors Beverage Co. (NYSE: TAP) last year to produce cannabis beverages and created six new cannabis beverage brands from it.

Molson Coors Beverage is the company behind classic beers like Coors Light and Blue Moon. Its name will help give HEXO a spotlight as cannabis is popularized.

Its stock has struggled through the pandemic. But when you look at its financials, the negativity is clearly hype-based.

HEXO reported a 17% increase in net revenue for Q2 2020, from $14.5 million to $17 million. Its adult-use marijuana sales increased by 57% from last quarter.

Even during the pandemic, this company is spending the year getting new licenses around Canada to distribute CBD products.

You can buy shares of HEXO for just $0.50 right now. But those are likely to pop to $1.08 before the year is over. That’s a gain of 116%.

Action to Take: The CBD market is growing. And you want to be holding shares of HEXO Corp. (NYSE: HEXO) before it soars. You can grab them for just $0.50 right now. Some analysts are targeting $1.08 within a year. So that’s a chance at 116% upside.

How One Formula Can Hand You the Best of Both Worlds

Tom Gentile has uncovered a low-cost, high-potential opportunity that’s practically tailor-made for today’s market.

Anyone can get started with as little as $371… and in just a few weeks, you could walk away with a fortune.

It’s all thanks to one special formula…

Follow Money Morning onFacebook and Twitter.

About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.

Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.

Source: Money Morning